External Vagal Nerve Stimulator GammaCore
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/16/2019
Pipeline Type
New Therapeutic Devices
Phase Of Development
N/A
Sponsors and Collaborators
ElectroCore
Mechanism of Action
Mechanism Description
gammaCore® (nVNS) is the first non-invasive, hand-held medical therapy applied at the neVNS. Approved by FDA for migraines. CE mark in EU for adjuntive therapy for seizures
Populations Tested In
For adults with focal and generalized seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link